{"id":"dapivirine-vaginal-ring-004","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or discomfort"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Vulvovaginal candidiasis"},{"rate":null,"effect":"Abnormal vaginal discharge"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dapivirine inhibits HIV reverse transcriptase, preventing the virus from converting its RNA genome into DNA and integrating into host cells. The vaginal ring formulation provides sustained local and systemic drug delivery over several weeks, offering long-acting HIV prevention. This approach aims to provide women with a discreet, user-controlled contraceptive-like method for HIV pre-exposure prophylaxis (PrEP).","oneSentence":"Dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV replication when released from a vaginal ring formulation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:39.113Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 prevention in women (pre-exposure prophylaxis)"}]},"trialDetails":[{"nctId":"NCT05416021","phase":"PHASE1","title":"Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2022-08-01","conditions":"HIV Infections","enrollment":124},{"nctId":"NCT02010593","phase":"PHASE2","title":"Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-12","conditions":"Human Immunodeficiency Virus","enrollment":96},{"nctId":"NCT02862171","phase":"PHASE3","title":"To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2016-07-12","conditions":"HIV Prevention","enrollment":941},{"nctId":"NCT01755741","phase":"PHASE1","title":"Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-02","conditions":"Human Immunodeficiency Virus","enrollment":70},{"nctId":"NCT01731574","phase":"PHASE1","title":"DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2012-12","conditions":"HIV","enrollment":36},{"nctId":"NCT02858024","phase":"PHASE1","title":"A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2015-01-12","conditions":"HIV","enrollment":16},{"nctId":"NCT02847286","phase":"PHASE1","title":"To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2015-09-01","conditions":"HIV- Prevention","enrollment":36},{"nctId":"NCT01952561","phase":"PHASE1","title":"Expanded Use PK of Dapivirine Vaginal Ring","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-11","conditions":"Pharmacokinetics","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TMC-120"],"phase":"phase_3","status":"active","brandName":"Dapivirine Vaginal Ring-004","genericName":"Dapivirine Vaginal Ring-004","companyName":"International Partnership for Microbicides, Inc.","companyId":"international-partnership-for-microbicides-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV replication when released from a vaginal ring formulation. Used for HIV-1 prevention in women (pre-exposure prophylaxis).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}